Regulus Therapeutics Inc (RGLS) — Capital Reinvestment Ratio
Regulus Therapeutics Inc (RGLS) has a Capital Reinvestment Ratio of 0.07x as of December 2020, meaning it reinvests 0% of its operating cash flow ($3.19 Million) in capital expenditures ($237.00K). Check tangible net worth ratio of Regulus Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Regulus Therapeutics Inc Capital Reinvestment Ratio (2010–2010)
This chart tracks Regulus Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Regulus Therapeutics Inc operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Regulus Therapeutics Inc (2010–2010)
Year-by-year Capital Reinvestment Ratio for Regulus Therapeutics Inc from 2010 to 2010. See Regulus Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.20x | $12.31 Million | $2.42 Million | — |